{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:32:11Z","timestamp":1793151131650,"version":"4.5.0"},"reference-count":63,"publisher":"Portland Press Ltd.","issue":"4","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,2,1]]},"abstract":"<jats:p>Over the last 20\u00a0years it has become recognized that low-grade inflammation plays a role in cardiovascular disease. More recently, participation of the innate and the adaptive immune response in mechanisms that contribute to inflammation in cardiovascular disease has been reported in atherosclerosis and hypertension. Different subsets of lymphocytes and their cytokines are involved in vascular remodelling in hypertension, chronic kidney disease and heart disease. Effector T-cells include Th1 (interferon-\u03b3-producing) and Th2 (interleukin-4 producing) lymphocytes, as well as Th17 (which produce interleukin-17) and T-suppressor lymphocytes such as Treg-cells (regulatory T-cells), which express the transcription factor Foxp3 (forkhead box P3) and participate respectively as pro- and anti-inflammatory cells. Pro-inflammatory T-lymphocytes participate in mechanisms of cardiovascular disease in part by mediating the effects of angiotensin II and mineralocorticoids. Involvement of immune mechanisms in cardiac, vascular and renal changes in hypertension has been demonstrated in many experimental models, an example being the Dahl-salt sensitive rat and the spontaneously hypertensive rat. How activation of immunity is triggered remains unknown, but neo-antigens could be generated by elevated blood pressure through damage-associated molecular pattern receptors or other mechanisms. Once activated, Th1 cells may contribute to blood pressure elevation by affecting the kidney, vascular remodelling of blood vessels directly via the effects of the cytokines produced or through their effects on perivascular fat. Treg-cells protect from blood pressure elevation by acting upon similar targets. Recent data suggests that participation of these mechanisms that have been demonstrated already in murine models also occurs in humans. These novel findings may open the way for new therapeutic approaches to improve outcomes in hypertension and cardiovascular disease in humans.<\/jats:p>","DOI":"10.1042\/cs20130407","type":"journal-article","created":{"date-parts":[[2013,10,14]],"date-time":"2013-10-14T14:35:19Z","timestamp":1381761319000},"page":"267-274","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":164,"title":["Immune mechanisms in hypertension and vascular injury"],"prefix":"10.1042","volume":"126","author":[{"given":"Ernesto\u00a0L.","family":"Schiffrin","sequence":"first","affiliation":[{"name":"Lady Davis Institute for Medical Research and Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, PQ, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2013,10,14]]},"reference":[{"key":"2021113010300190600_B1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00041552-200303000-00009","article-title":"Vascular inflammation: a role in vascular disease in hypertension?","volume":"12","author":"Virdis","year":"2003","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"2021113010300190600_B2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/CS20060247","article-title":"Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions","volume":"112","author":"Savoia","year":"2007","journal-title":"Clin. Sci."},{"key":"2021113010300190600_B3","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1161\/HYPERTENSIONAHA.108.120253","article-title":"Immunology in hypertension, preeclampsia, and target-organ damage","volume":"54","author":"Verlohren","year":"2009","journal-title":"Hypertension"},{"key":"2021113010300190600_B4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1161\/HYPERTENSIONAHA.110.163576","article-title":"Inflammation, immunity and hypertension","volume":"57","author":"Harrison","year":"2011","journal-title":"Hypertension"},{"key":"2021113010300190600_B5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s11906-011-0224-9","article-title":"Immune mechanisms in hypertension","volume":"13","author":"Leibowitz","year":"2011","journal-title":"Curr. Hypertens. Rep."},{"key":"2021113010300190600_B6","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1161\/01.HYP.0000128335.45571.ce","article-title":"Tooth loss has been associated with increased risk of incident hypertension in postmenopausal women","volume":"43","author":"Taguchi","year":"2004","journal-title":"Hypertension"},{"key":"2021113010300190600_B7","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa063186","article-title":"Treatment of periodontal disease and endothelial function","volume":"356","author":"Tonetti","year":"2007","journal-title":"New Eng. J. Med."},{"key":"2021113010300190600_B8","first-page":"523","article-title":"Evidence for an initial, thymus independent and a chronic, thymus dependent phase of DOCA and salt hypertension in mice","volume":"84","author":"Svendsen","year":"1976","journal-title":"Acta Pathol. Microbiol. Scand. A"},{"key":"2021113010300190600_B9","first-page":"1","article-title":"Transfer of arterial hypertension by splenic cells from DOCA-salt hypertensive and renal hypertensive rats to normotensive recipients","volume":"88","author":"Olsen","year":"1980","journal-title":"Acta Pathol. Microbiol. Scand. C"},{"key":"2021113010300190600_B10","first-page":"120","article-title":"Immunological depression in spontaneously hypertensive rats","volume":"40","author":"Takeichi","year":"1980","journal-title":"Clin. Exp. Immunol."},{"key":"2021113010300190600_B11","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1046\/j.1523-1755.2001.00737.x","article-title":"Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure","volume":"59","author":"Rodriguez-Iturbe","year":"2001","journal-title":"Kidney Int."},{"key":"2021113010300190600_B12","first-page":"F515","article-title":"Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension","volume":"295","author":"Crowley","year":"2008","journal-title":"Am. J. Physiol."},{"key":"2021113010300190600_B13","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1161\/01.ATV.0000181743.28028.57","article-title":"Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury","volume":"25","author":"De Ciuceis","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2021113010300190600_B14","first-page":"H1789","article-title":"Resistance artery remodeling in deoxycorticosterone acetate-salt hypertension is dependent on vascular inflammation: evidence from m-csf deficient mice","volume":"292","author":"Ko","year":"2007","journal-title":"Am. J. Physiol."},{"key":"2021113010300190600_B15","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/01.ATV.0000066684.37829.16","article-title":"NAD(P)H oxidase mediates angiotensin II-induced vascular macrophage infiltration and medial hypertrophy","volume":"23","author":"Liu","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2021113010300190600_B16","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1161\/CIRCULATIONAHA.111.034470","article-title":"Lysozyme M-positive monocytes mediate angiotensin II-induced arterial hypertension and vascular dysfunction","volume":"124","author":"Wenzel","year":"2011","journal-title":"Circulation"},{"key":"2021113010300190600_B17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/01.HYP.0000075082.06183.4E","article-title":"Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury","volume":"42","author":"Shao","year":"2003","journal-title":"Hypertension"},{"key":"2021113010300190600_B18","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1084\/jem.20070657","article-title":"Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction","volume":"204","author":"Guzik","year":"2007","journal-title":"J. Exp. Med."},{"key":"2021113010300190600_B19","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1161\/CIRCULATIONAHA.107.760116","article-title":"Novel role for inhibitor of differentiation 2\u00a0in the genesis of angiotensin II-induced hypertension","volume":"117","author":"Gratze","year":"2008","journal-title":"Circulation"},{"key":"2021113010300190600_B20","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.109.145094","article-title":"Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction","volume":"55","author":"Madhur","year":"2010","journal-title":"Hypertension"},{"key":"2021113010300190600_B21","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1161\/HYPERTENSIONAHA.111.173856","article-title":"Role of T lymphocytes in angiotensin II-mediated microvascular thrombosis","volume":"58","author":"Senchenkova","year":"2011","journal-title":"Hypertension"},{"key":"2021113010300190600_B22","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/HJH.0b013e32835bcce1","article-title":"The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies","volume":"31","author":"Armstrong","year":"2013","journal-title":"J. Hypertens."},{"key":"2021113010300190600_B23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/HYPERTENSIONAHA.109.142646","article-title":"Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system","volume":"55","author":"Lob","year":"2010","journal-title":"Hypertension"},{"key":"2021113010300190600_B24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1161\/HYPERTENSIONAHA.111.187021","article-title":"Vascular remodeling in hypertension: mechanisms and treatment","volume":"59","author":"Schiffrin","year":"2012","journal-title":"Hypertension"},{"key":"2021113010300190600_B25","first-page":"R1089","article-title":"Lymphocyte responses exacerbate angiotensin II-dependent hypertension","volume":"298","author":"Crowley","year":"2010","journal-title":"Am. J. Physiol."},{"key":"2021113010300190600_B26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/HYPERTENSIONAHA.110.154302","article-title":"High dietary protein exacerbates hypertension and renal damage in Dahl SS rats by increasing infiltrating immune cells in the kidney","volume":"57","author":"De Miguel","year":"2011","journal-title":"Hypertension"},{"key":"2021113010300190600_B27","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1161\/CIRCULATIONAHA.110.991059","article-title":"T cells and blood vessels: costimulation turns up the pressure","volume":"122","author":"Bu","year":"2010","journal-title":"Circulation"},{"key":"2021113010300190600_B28","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1161\/CIRCULATIONAHA.109.930446","article-title":"Inhibition and genetic ablation of the B7\/CD28 T-cell costimulation axis prevents experimental hypertension","volume":"122","author":"Vinh","year":"2010","journal-title":"Circulation"},{"key":"2021113010300190600_B29","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1101\/gr.229102","article-title":"The human genome browser at UCSC","volume":"12","author":"Kent","year":"2002","journal-title":"Genome Res."},{"key":"2021113010300190600_B30","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-201X.2004.01334.x","article-title":"Consomic rat model systems for physiological genomics","volume":"181","author":"Cowley","year":"2004","journal-title":"Acta Physiol. Scand."},{"key":"2021113010300190600_B31","first-page":"H938","article-title":"Immune regulation and vascular inflammation in genetic hypertension","volume":"298","author":"Viel","year":"2010","journal-title":"Am. J. Physiol."},{"key":"2021113010300190600_B32","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1161\/HYPERTENSIONAHA.110.162941","article-title":"T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury","volume":"57","author":"Barhoumi","year":"2011","journal-title":"Hypertension"},{"key":"2021113010300190600_B33","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1161\/CIRCULATIONAHA.108.832782","article-title":"Regulatory T cells ameliorate angiotensin II-induced cardiac damage","volume":"119","author":"Kvakan","year":"2009","journal-title":"Circulation"},{"key":"2021113010300190600_B34","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/HYPERTENSIONAHA.111.181123","article-title":"T regulatory lymphocytes prevent aldosterone-induced vascular injury","volume":"59","author":"Kasal","year":"2012","journal-title":"Hypertension"},{"key":"2021113010300190600_B35","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1161\/CIRCULATIONAHA.106.678474","article-title":"CXCR6 promotes atherosclerosis by supporting T-cell homing, interferon-\u03b3 production, and macrophage accumulation in the aortic wall","volume":"116","author":"Galkina","year":"2007","journal-title":"Circulation"},{"key":"2021113010300190600_B36","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/01.mol.0000182532.11512.90","article-title":"Regulatory T cell responses: potential role in the control of atherosclerosis","volume":"16","author":"Mallat","year":"2005","journal-title":"Curr. Opin. Lipidol."},{"key":"2021113010300190600_B37","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nm1343","article-title":"Natural regulatory cells control the development of atherosclerosis in mice","volume":"12","author":"Ait-Oufella","year":"2006","journal-title":"Nat. Med."},{"key":"2021113010300190600_B38","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.4049\/jimmunol.180.4.2686","article-title":"CD11b+ monocytes abrogate Th17 CD4+ T cell-mediated experimental autoimmune myocarditis","volume":"180","author":"Valaperti","year":"2008","journal-title":"J. Immunol."},{"key":"2021113010300190600_B39","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"2021113010300190600_B40","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.1128\/IAI.00542-08","article-title":"CTLA-4 blockade abrogates protection by regulatory T cells in a mouse model of microbially-induced innate immune-driven colitis","volume":"76","author":"Watanabe","year":"2008","journal-title":"Infect. Immun."},{"key":"2021113010300190600_B41","doi-asserted-by":"crossref","first-page":"6780","DOI":"10.4049\/jimmunol.177.10.6780","article-title":"T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5\u2032-adenosine monophosphate to adenosine","volume":"177","author":"Kobie","year":"2006","journal-title":"J. Immunol."},{"key":"2021113010300190600_B42","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.immuni.2009.04.010","article-title":"Mechanisms of Foxp3+ T regulatory cell-mediated suppression","volume":"30","author":"Shevach","year":"2009","journal-title":"Immunity"},{"key":"2021113010300190600_B43","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/107999099313695","article-title":"The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes","volume":"19","author":"Donnelly","year":"1999","journal-title":"Interferon Cytokine Res."},{"key":"2021113010300190600_B44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0165-5728(01)00444-1","article-title":"IL-10 promotes survival of microglia without activating Akt","volume":"122","author":"Strle","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"2021113010300190600_B45","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1093\/emboj\/20.14.3760","article-title":"Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology","volume":"20","author":"Kontoyiannis","year":"2001","journal-title":"EMBO J."},{"key":"2021113010300190600_B46","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nm0302-240","article-title":"Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10\u00a0in mice","volume":"8","author":"Lee","year":"2002","journal-title":"Nat. Med."},{"key":"2021113010300190600_B47","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.188.2.287","article-title":"CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in\u00a0vitro by inhibiting interleukin 2 production","volume":"188","author":"Thornton","year":"1998","journal-title":"J. Exp. Med."},{"key":"2021113010300190600_B48","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1182\/blood-2006-04-016451","article-title":"Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells","volume":"109","author":"Garin","year":"2007","journal-title":"Blood"},{"key":"2021113010300190600_B49","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.immuni.2004.09.002","article-title":"Human T regulatory cells can use the perforin pathway to cause autologous target cell death","volume":"21","author":"Grossman","year":"2004","journal-title":"Immunity"},{"key":"2021113010300190600_B50","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.4049\/jimmunol.174.4.1783","article-title":"Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism","volume":"174","author":"Gondek","year":"2005","journal-title":"J. Immunol."},{"key":"2021113010300190600_B51","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.4049\/jimmunol.172.8.4676","article-title":"Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells","volume":"172","author":"Misra","year":"2004","journal-title":"J. Immunol."},{"key":"2021113010300190600_B52","doi-asserted-by":"crossref","first-page":"10113","DOI":"10.1073\/pnas.0711106105","article-title":"Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in\u00a0vitro and actively inhibit their maturation","volume":"105","author":"Onishi","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113010300190600_B53","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression","volume":"204","author":"Deaglio","year":"2007","journal-title":"J. Exp. Med."},{"key":"2021113010300190600_B54","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4049\/jimmunol.180.1.249","article-title":"Targeted deletion of fgl2 leads to impaired regulatory T cell activity and development of autoimmune glomerulonephritis","volume":"180","author":"Shalev","year":"2008","journal-title":"J. Immunol."},{"key":"2021113010300190600_B55","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1161\/HYPERTENSIONAHA.109.137158","article-title":"Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction","volume":"54","author":"Didion","year":"2009","journal-title":"Hypertension"},{"key":"2021113010300190600_B56","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1161\/ATVBAHA.111.233262","article-title":"Interleukin-10 Released by CD4+CD25+ natural regulatory T cells improves activity in hypertensive mice microvascular endothelial function through inhibition of NADPH oxidase","volume":"31","author":"Kassan","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2021113010300190600_B57","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/01.CIR.98.8.731","article-title":"Prospective study of C-reactive protein and the risk of future cardiovascular events in apparently healthy women","volume":"98","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"2021113010300190600_B58","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1161\/01.CIR.0000104566.10178.AF","article-title":"Blood pressure, C-reactive protein, and risk of future cardiovascular events","volume":"108","author":"Blake","year":"2003","journal-title":"Circulation"},{"key":"2021113010300190600_B59","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/xJAHA.111.000125","article-title":"Effector memory T cells are associated with atherosclerosis in humans and animal models","volume":"1","author":"Ammirati","year":"2012","journal-title":"J. Am. Heart Assoc."},{"key":"2021113010300190600_B60","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jama.2012.6698","article-title":"Arterial inflammation in patients With HIV","volume":"308","author":"Subramanian","year":"2012","journal-title":"JAMA, J. Am. Med. Assoc."},{"key":"2021113010300190600_B61","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/HJH.0b013e32835ca949","article-title":"Symmetric ambulatory arterial stiffness index and 24-h pulse pressure in HIV infection: results of a nationwide cross-sectional study","volume":"31","author":"Schillaci","year":"2013","journal-title":"J. Hypertens."},{"key":"2021113010300190600_B62","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1172\/JCI117222","article-title":"Vascular mechanisms of cyclosporininduced hypertension in the rat","volume":"93","author":"Roullet","year":"1994","journal-title":"J. Clin. Invest."},{"key":"2021113010300190600_B63","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/HYPERTENSIONAHA.113.00689","article-title":"Immunosenescent CD8+ T cells and C-X-C chemokine receptor type\u00a03 chemokines are increased in human hypertension","volume":"62","author":"Youn","year":"2013","journal-title":"Hypertension"}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/126\/4\/267\/444232\/cs1260267.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/126\/4\/267\/444232\/cs1260267.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T11:14:07Z","timestamp":1638270847000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/126\/4\/267\/69182\/Immune-mechanisms-in-hypertension-and-vascular"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,14]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,2,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20130407","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,14]]}}}